John F. DeBernardis

4.0k citations

64 papers · 3.2k indexed · 1 hit paper · h-index 23

Psychiatry and Mental health top 1%
- Dementia and Cognitive Impairment Research 10
Physiology top 1%
- Alzheimer's disease research and treatments 13
Neurology top 2%
Biological Psychiatry top 5%
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research 5
Molecular Biology
- Receptor Mechanisms and Signaling 18
Biochemistry
- Eicosanoids and Hypertension Pharmacology 8
Spectroscopy
- Analytical Chemistry and Chromatography 5
Organic Chemistry
- Asymmetric Synthesis and Catalysis 5
Cardiology and Cardiovascular Medicine
- Renin-Angiotensin System Studies 5

Co-authors: Daniel J. Kerkman Raymond Zinkowski Harald Hampel Katharina Büerger Stefan Teipel Peter Davies Marc G. Caron L.M. Fredrik Leeb-Lundberg
Cited by: Psychiatry and Mental health Physiology Neurology
Partner nations: United States United Kingdom Germany

In The Last Decade

John F. DeBernardis

64 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1985 Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism.

Peers

Countries citing papers authored by John F. DeBernardis

Since Specialization

Citations

This map shows the geographic impact of John F. DeBernardis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. DeBernardis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. DeBernardis more than expected).

Fields of papers citing papers by John F. DeBernardis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. DeBernardis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. DeBernardis. The network helps show where John F. DeBernardis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John F. DeBernardis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John F. DeBernardis Line = papers co-authored together John F. DeBernardis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Correlation of Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231 With Rates of Hippocampal Atrophy in Alzheimer Disease Harald Hampel,Katharina Bürger,Jens C. Pruessner,Raymond Zinkowski,John F. DeBernardis,Daniel J. Kerkman,Gerda Leinsinger,Alan C. Evans,Peter Davies,Hans‐Jürgen Möller,Stefan Teipel	2005	139
2	Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt–Jakob disease Katharina Büerger,Markus Otto,Stefan Teipel,Raymond Zinkowski,Kaj Blennow,John F. DeBernardis,Daniel J. Kerkman,Johannes Schröder,Peter Schönknecht,Lukas Cepek,Cheryl McCulloch,Hans‐Jürgen Möller,Jens Wiltfang,Hans A. Kretzschmar,Harald Hampel	2005	52
3	Increased levels of CSF phosphorylated tau in apolipoprotein E ɛ4 carriers with mild cognitive impairment Katharina Büerger,Stefan Teipel,Raymond Zinkowski,Trey Sunderland,Niels Andreasen,Kaj Blennow,Michael Ewers,John F. DeBernardis,Yong Shen,Daniel J. Kerkman,Yansheng Du,Harald Hampel	2005	23
4	Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations Quan Liu,Mark A. Smith,Jesús Ávila,John F. DeBernardis,Mayank Kansal,Atsushi Takeda,Xiongwei Zhu,Akihiko Nunomura,Kazuhiro Honda,Paula I. Moreira,Catarina R. Oliveira,Maria S. Santos,Shun Shimohama,Gjumrakch Aliev,Jack de la Torre,Hossein Ghanbari,Sandra L. Siedlak,Peggy L.R. Harris,Lawrence M. Sayre,George Perry	2004	105
5	Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease Harald Hampel,Katharina Büerger,Raymond Zinkowski,Stefan Teipel,Alexander Goernitz,Niels Andreasen,Magnus Sjoegren,John F. DeBernardis,Daniel J. Kerkman,Koichi Ishiguro,Hideto Ohno,Eugeen Vanmechelen,Hugo Vanderstichele,Cheryl McCulloch,Hans‐Jürgen Möller,Peter Davies,Kaj Blennow	2004	329
6	MRI and CSF studies in the early diagnosis of Alzheimer's disease Mony J. de Leon,Susan DeSanti,Raymond Zinkowski,P.D. Mehta,Domenico Praticò,S. Segal,Christopher M. Clark,Daniel J. Kerkman,John F. DeBernardis,J Li,Lindsey Lair,‌Barry Reisberg,Wai Tsui,Henry Rusinek	2004	160
7	Differentiation of Geriatric Major Depression From Alzheimer’s Disease With CSF Tau Protein Phosphorylated at Threonine 231 Katharina Büerger,Raymond Zinkowski,Stefan Teipel,Hiroyuki Arai,John F. DeBernardis,Daniel J. Kerkman,Cheryl McCulloch,Frank Padberg,Frank Faltraco,Alexander Goernitz,Tero Tapiola,Stanley I. Rapoport,Tuula Pirttilä,Hans‐Jürgen Möller,Harald Hampel	2003	69
8	Assessment of various standards in a sandwich assay that detects tau phosphorylated at threonine 231 in cerebrospinal fluid Raymond Zinkowski,Katharina Büerger,Daniel J. Kerkman,John F. DeBernardis,Christopher C.J. Miller,Harald Hampel,Peter Davies	2001	1
9	Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients Russell E. Kohnken,Katharina Büerger,Raymond Zinkowski,Caudill Miller,Daniel J. Kerkman,John F. DeBernardis,Jifang Shen,Hans‐Jürgen Möller,Peter Davies,Harald Hampel	2000	142
10	Cardiovascular Effects of Orally Administered ABBOTT-81988, an Angiotensin II Antagonist, in Conscious Spontaneously Hypertensive Rats Jang Yun Lee,Robert B. Warner,Michael E. Brune,Andrew Adler,Martin Winn,Biswanath De,Thomas M. Zydowsky,Terry J. Opgenorth,Daniel J. Kerkman,John F. DeBernardis	1994	2
11	[3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors Arthur A. Hancock,Bruce W. Surber,Gary Rotert,Samuel Thomas,Andrew S. Tasker,Bryan K. Sorensen,Alex D. Vodenlich,T. J. Opgenorth,Daniel J. Kerkman,John F. DeBernardis	1994	3
12	Synthesis and structure activity relationships of cis- and trans-2,3,4,4a,9,9a-hexahydro-1H-indeno[2,1-c]pyridines for 5-HT receptor subtypes Michael D. Meyer,John F. DeBernardis,A. A. Hancock	1994	21
13	Receptor Interactions of Abbott-81988, A Highly Potent, Non-Peptide Angiotensin-II Antagonist Selective for Type-1 Receptors Arthur A. Hancock,Steven A. Buckner,J. Y. Lee,M.E. Brune,Patricia A. Morse,K. Oheim,Robert B. Warner,Martin Winn,Thomas M. Zydowsky,B De,Daniel J. Kerkman,John F. DeBernardis	1994	1
14	Pharmacological characterization of abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors Arthur A. Hancock,Steven A. Buckner,J.Y. Lee,M.E. Brune,Patricia A. Morse,K. Oheim,Robert B. Warner,Martin Winn,Thomas M. Zydowsky,B De,Daniel J. Kerkman,John F. DeBernardis	1993	2
15	Orthostatic hypotension occurs following α₂‐adrenoceptor blockade in chronic prazosin‐pretreated conscious spontaneously hypertensive rats J. Y. Lee,M.E. Brune,Robert B. Warner,John F. DeBernardis	1992	6
16	Discovery of a novel class of orally active, non-peptide angiotensin II antagonists B De,Martyn Winn,Thomas M. Zydowsky,Daniel J. Kerkman,John F. DeBernardis,Jung-Hee Lee,Samuel L. Buckner,Robert B. Warner,Mats Brune	1992	32
17	Molecular Design of Novel Ligands for 5-HT_1AReceptors Arthur A. Hancock,Michael D. Meyer,John F. DeBernardis	1991	5
18	Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension. J Y Lee,John F. DeBernardis	1990	2
19	Differentiation of Alpha-Adrenergic Receptors Using Pharmacological Evaluation and Molecular Modeling of Selective Adrenergic Agents Arthur A. Hancock,John J. Kyncl,Yvonne C. Martin,John F. DeBernardis	1988	13
20	Similarity of Central and Peripheral Alpha-1 Adrenoceptors in Rat and Rabbit Eugene N. Bush,Donna E. Walker,Dusanka Stanisic,John F. DeBernardis,John J. Kyncl	1987	2

About John F. DeBernardis

John F. DeBernardis is a scholar working on Biochemistry, Psychiatry and Mental health and Physiology, having authored 64 papers that have together received 3.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (18 papers), Alzheimer's disease research and treatments (13 papers), Dementia and Cognitive Impairment Research (10 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Analytical Chemistry and Chromatography (5 papers), Asymmetric Synthesis and Catalysis (5 papers), Neuroscience and Neuropharmacology Research (5 papers) and Renin-Angiotensin System Studies (5 papers). The work is most often cited by research in Psychiatry and Mental health (1.2k citations), Physiology (1.8k citations) and Neurology (471 citations). John F. DeBernardis has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Daniel J. Kerkman, Raymond Zinkowski, Harald Hampel, Katharina Büerger, Stefan Teipel, Peter Davies, Marc G. Caron, L.M. Fredrik Leeb-Lundberg, Robert J. Lefkowitz and Jon W. Lomasney.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact